SPDR® S&P® Biotech ETF
XBI NYSE Arca
The SPDR® S&P® Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P® Biotechnology Select Industry™ Index. The fund seeks to track a modified equal weighted index which provides the potential for unconcentrat...
Hover to inspectDrag to measure a move← → to step through days
- Fund size
- 3.89B as of Feb 2020
- Expense ratio
- 0.35% per year
- Dividend yield
- 0.35% Quarterly
- Volatility · 1Y
- 29.2% Above Average
- Beta
- 0.98 vs the market
- 52-week range
- 107.59169.55
How XBI has paid off
Price return over every period, and total return with dividends reinvested, set against price alone.
Return by period
Price · to Oct 30Total return vs price return
Price onlyOver 1 year, XBI returned +43.1% with dividends reinvested — dividends added +0.5 pts to the price move.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±29% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −14.9% on Oct 16, 2026 — 58 days after the previous high
More than 5% below a high 37% of the time.
Market sensitivity
BetaA beta of 0.98 means XBI has moved roughly in line with the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Uptrend- 12-day average153.55 +1.6%
- 26-day average153.48 +1.6%
- 50-day average154.04 +1.3%
- 200-day average141.64 +10.1%
The price is above 4 of 4 averages. The 50-day average is above the 200-day, a sign of a rising longer-term trend.
Relative strength (RSI)
NeutralRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
Inside the fund
Health Care · Biotech — tracking the S&P® Biotechnology Select Industry™ Index.
- Assets under management3.89BUSD
- Expense ratio0.35%per year
- Holdings124
- Risk score5.0Medium
Launched February 2006. Listed options available. Fund data as of Feb 28, 2020.
What it pays you
Cash distributions over the last twelve months, and how they have grown.
About 3 USD a year for every 1,000 USD invested at today's price.
- Per share
- 0.55
- Frequency
- Quarterly
- Last paid
- Jun 22, 2026
Last 12 months
0.41 USD / shareWhere XBI shows up
Curated themes and indices that hold XBI. Open one to see it in context, or test the whole theme in a portfolio.
About SPDR® S&P® Biotech ETF
The SPDR® S&P® Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P® Biotechnology Select Industry™ Index. The fund seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks
- Featured in 3 curated themes
- 124 holdings
- Ticker
- XBI
- Exchange
- NYSE Arca
- ISIN
- US78464A8707
- CUSIP
- 78464A870
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- Health Care
- Industry
- Biotech
- Benchmark
- S&P® Biotechnology Select Industry™ Index
All key statistics
Details
Shareas of Oct 30, 2026
Dataas of Feb 28, 2020
Put XBI to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.